• How to develop cancer drugs faster, with Ellipses Pharma

  • Jan 17 2024
  • Duración: 23 m
  • Podcast

How to develop cancer drugs faster, with Ellipses Pharma Por arte de portada

How to develop cancer drugs faster, with Ellipses Pharma

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • This week we are speaking with the chief executive of British drug development company Ellipses Pharma.

    Founded in 2018 to create new cancer therapies, the firm is following a unique multimodal approach to clinical development, leveraging a variety of technologies.

    That’s not the only way that Ellipses is rethinking drug development. The company uses a consultative model to provide an unbiased vetting process for candidates, with the goal of de-risking initial asset selection.

    Ellipses also wants to make sure that capital is invested in the most efficient way, pursuing a portfolio-based strategy which ensures uninterrupted development capital for each asset.

    Our guest on the show is Ellipses CEO and co-founder, Dr Rajan Jethwa.
    Más Menos
activate_primeday_promo_in_buybox_DT
Política y Gobierno
Más Menos

Lo que los oyentes dicen sobre How to develop cancer drugs faster, with Ellipses Pharma

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles